Correction to Efficacy and Safety of Hypofractionated Radiotherapy With a Simultaneous Integrated Boost and With a Sequential Boost After Breast-Conserving Surgery

IF 3.1 2区医学 Q2 ONCOLOGY

Cancer Medicine Pub Date : 2025-05-05 DOI:10.1002/cam4.70882

引用次数: 0

Abstract

Li, N., Zhou, Y., Wang, J., Wang, Y., Shao, R., Yang, H., Xiong, W., Zheng, X. and Wang, X. (2025), Efficacy and Safety of Hypofractionated Radiotherapy With a Simultaneous Integrated Boost and With a Sequential Boost After Breast-Conserving Surgery. Cancer Med, 14: e70630. https://doi.org/10.1002/cam4.70630

The penultimate sentence “The effect of the boost on the tumor bed is unclear, especially in patients receiving hypofractionated whole- breast radiotherapy. (delete…)” in the second paragraph of the discussion section needs to be deleted.

We apologize for this error.

查看原文本刊更多论文

对保乳手术后低分割放疗同时综合强化和序贯强化的疗效和安全性的修正

李楠，周艳，王军，王艳，邵如，杨辉，熊伟，郑晓和王晓霞（2025），保乳术后低分割放疗同步综合强化与序次强化的疗效与安全性。癌症医学杂志，14:70630。https://doi.org/10.1002/cam4.70630The倒数第二句“增强对肿瘤床的影响尚不清楚，特别是在接受低分割全乳放疗的患者中。（删除…）”，需要删除讨论部分第二段。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Medicine ONCOLOGY-

CiteScore

5.50

自引率

2.50%

发文量

907

审稿时长

19 weeks

期刊介绍： Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.